Hyperspectral Cell Detection Using AI Spectral Classification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional dyes like H&E struggle to provide sufficient contrast for early stage cancer cells, leading to their oversight during visual inspection by pathologists, resulting in missed treatment opportunities.
Innovation Solution
A hyperspectral imaging system combined with machine learning models is used to analyze tissue samples, generating pixel spectral signatures and training algorithms to differentiate between normal and anomalous cells based on their spectral data, enabling accurate classification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional H&E staining is used, then the imaging process is simple and quick, but the contrast between early stage cancer cells and normal cells is insufficient
Solution Approach 1:
The patent changes the imaging parameter from conventional white light to hyperspectral imaging across multiple wavelengths (400-2500 nm). This parameter change enables detection of spectral signatures that differentiate cancerous cells from normal cells, achieving superior contrast and detection accuracy without requiring complex multi-step staining procedures
Solution Approach 2:
The patent replaces the mechanical/chemical staining process (H&E staining) with an optical spectral analysis system. Instead of relying on dye penetration and color contrast, the system uses hyperspectral imaging to capture and analyze the spectral characteristics of cells directly, eliminating the need for complex staining protocols while improving detection capability
2Measurement precision
If visual inspection by pathologists is used, then the process is straightforward, but human visual limitations cause early stage cancers to be overlooked
Solution Approach 1:
The patent replaces human visual inspection with an automated hyperspectral imaging and machine learning system. The system captures hyperspectral data, extracts spectral signatures, and uses trained models to automatically identify and classify cells, eliminating human visual limitations and providing consistent, objective detection of early stage cancers
Solution Approach 2:
The patent introduces machine learning models as an intermediary between the hyperspectral imaging system and the detection decision. The trained models process the spectral data, extract features, and classify cells based on learned patterns, enabling accurate automated detection that surpasses human pathologist capabilities
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the detection of anomalous cells by reducing human subjectivity and improving the accuracy of identifying early stage cancers.
Implementation Method 1
receive a patient hyperspectral image comprising a pixel spectral signature for each pixel of the received patient hyperspectral image
Data Source
AI summary
According to certain embodiments, a system for detection of anomalous cells, comprises a hyperspectral imaging system; a memory having executable instructions stored thereon; and a processor configured to execute the executable instructions to cause the system to: receive a patient hyperspectral image comprising a pixel spectral signature for each pixel of the received patient hyperspectral image; classify the patient hyperspectral image by a machine learning model trained to classify hyperspectral images based on pixel spectral signatures; and provide an indication that the patient hyperspectral image contains an anomalous cell type, responsive to the classifying.